Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Other(1)

Detailed Status

Completed2

Recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

completed250%

recruiting125%

unknown125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingnot_applicable

Fungal Empyema Thoracis

NCT07337993

unknownphase_2

Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation

NCT06166524

completednot_applicable

Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes

NCT02086019

completednot_applicable

Active Detection of the Extension of Atherothrombosis in High Risk Coronary Patients

NCT00445835

Clinical Trials (4)

Showing 4 of 4 trials

NCT07337993Not Applicable

Fungal Empyema Thoracis

Recruiting

NCT06166524Phase 2

Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation

Unknown

NCT02086019Not Applicable

Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes

Completed

NCT00445835Not Applicable

Active Detection of the Extension of Atherothrombosis in High Risk Coronary Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4